Donepezil is a generic prescription drug used to treat dementia due to Alzheimer’s disease. Donepezil’s cost may depend on factors such as your dosage, whether you have health insurance, and the ...
Oral medications may be covered by a stand-alone Medicare Part D plan or a Medicare Advantage Prescription Drug (MAPD) plan. Both types of plans are approved by Medicare but administered by private ...
High doses of the Alzheimer's drug Aricept should be banned because they are no more effective than low doses and have a sharply increased risk of adverse effects, the advocacy group Public Citizen ...
TOKYO, July 17 (Reuters) - Japan's Eisai Co. Ltd <4523.T> on Tuesday unveiled a raft of new drug candidates in early stage trials and fleshed out plans to limit the fall-off in sales of Aricept ...
Donepezil, marketed under the brand name Aricept, is an oral tablet medication prescribed for people living with Alzheimer's disease. Medicare drug plans may cover the brand drug Aricept or its ...
April 2, 2012 — Approval for the new 23-mg dose of the Alzheimer's disease (AD) drug donepezil (Aricept, Eisai) "breached the FDA's own regulatory standard" and has led to "incomplete and distorted ...
An article in The British Medical Journal (BMJ) claims the US Food and Drug Administration (FDA) approved a higher-dose version of Eisai's blockbuster Alzheimer's drug Aricept 23 (donepezil) despite ...
BOSTON, Oct 3 (Reuters) - The drug Aricept does nothing to quell the agitation and aggression seen in more than a quarter of people with Alzheimer's disease, a British study has found. The study ...
Aricept (donepezil) is a tablet medication prescribed for people living with Alzheimer’s disease. Medicare drug plans may cover Aricept or its generic version, but the exact coverage and a person’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results